Pharmaceuticals

“We try to take smart risks”: Sandoz International’s business-focused reproach to rights management

How Sandoz International, this year’s WTR Industry Awards Healthcare and Life Sciences Team of the Year, adapts its enforcement strategies to keep one step ahead of infringers.

Read more

ECJ issues preliminary ruling on relabelling and exhaustion of trademark rights

The Court of Justice of the European Union has issued a preliminary ruling on the interpretation of Article 13(2) of Regulation 207/2009. The case involved parallel-imported medical devices that were marketed in Germany after being relabelled...

Read more

South Africa a step closer to plain packaging tobacco products

In a move that brings South Africa a step closer to plain packaging for tobacco products, the Department of Health has invited public comment on the Draft Control of Tobacco Products and Electronic Delivery Systems Bill 2018.

Read more

Have you been 'adversely affected' by a trademark decision?

In CeramTec GmbH v EUIPO, the EU General Court has provided some guidance as to what it means to be ‘adversely affected’ by a decision of the EUIPO.

Read more

Rapper Dr Dre's opposition to DR. DRAI for health-related services dismissed

The US Trademark Trial and Appeal Board has dismissed rapper Dr. Dre's opposition to the registration of the word mark DR. DRAI and the figurative mark DOCTOR DRAI for goods and services in the field of women's and men's health.

Read more

The world’s leading corporate trademark professionals revealed

Released today, Apple, Mars and Procter & Gamble head up the 2018 edition of the WTR 300: The World’s Leading Corporate Trademark Professionals. Now in its second edition, this community-led research project identifies the leading lights of the corporate...

Read more

WTR Industry Awards 2018: the shortlist revealed

The WTR Industry Awards 2018 honour leading trademark teams and individuals across a range of sectors. We reveal the shortlist.

Read more

WHOIS access charges, NGOs take aim at watch list plans and INTA applauds ‘Brand India’: news round-up

In our latest round-up, we look at a registry’s plans to charge trademark owners for access to WHOIS data and the war of words over plans for an IP markets watch list.

Read more

How the legal profession underutilises paralegals: exclusive interview with Deborah Hampton of Chemours

In the latest of our interview series with leading in-house counsel, The Chemours Company’s Deborah Hampton reflects on how paralegals are often underestimated and her approach to protecting the company’s global brand...

Read more

Procedures and strategies for pharmaceutical brands: Chile

Two frameworks are applicable to pharmaceutical marks in Chile. The Industrial Property Law and its regulation set out the rules for the registration and use of trademarks; the Sanitary Code and Decree 3/2010 regulate the pharmaceutical product marketing authorisation...

Read more

Procedures and strategies for pharmaceutical brands: Canada

Sweeping amendments to the Trademarks Act are expected to be implemented in 2019. The amendments will fundamentally affect the way in which all trademark owners will need to approach their selection, clearance and registration strategies, and the pharmaceutical...

Read more

Procedures and strategies for pharmaceutical brands: Brazil

Brazil is a first-to-file jurisdiction, and therefore IP rights are acquired only when an application is filed and registered with the Brazilian Patent and Trademark Office. However, pharmaceutical trademarks fall under two separate and independent statutory regimes...

Read more

Procedures and strategies for pharmaceutical brands: France

In order for a pharmaceutical trademark to be registered, no prior authorisation is needed per se. Unlike in other countries, in France the trademark owner is independent from the party exploiting the trademark and need not possess a particular quality.

Read more

Healthcare market robust – brands prosper while Chinese filings dominate: exclusive data analysis

In our latest industry data report, we explore the thriving and evolving healthcare industry. Our in-depth analysis reveals the trends driving this evolution, while also analysing key trademark filing statistics in this space...

Read more

Big changes in the pharmaceutical sector as leading brands flourish

A deep dive into key data about the pharmaceuticals sector suggests that over-regulation and availability of skills and technology remain key challenges; while the leading brands continue to rise in value, most are still filing in single classes only.

Read more

Big changes in the pharmaceutical sector as leading brands flourish: exclusive data analysis

In this week’s data report, we turn the spotlight on the sprawling pharmaceutical sector. We look at how the sector is being affected by political pressures, and identify the developments that are driving change.

Read more
Close

Register for more free content

  • Read more World Trademark Review blogs and articles
  • Receive the editor's weekly review by email
Register now  
Issue 73
;